Skip to main content
Y

Yixintang Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002727 LEI · 300300NE1YJT00E9JD69 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,819 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002727

About Yixintang Pharmaceutical Group Co., Ltd.

https://www.hx8886.com

Yixintang Pharmaceutical Group Co., Ltd. operates an extensive network of retail pharmacies providing a broad spectrum of healthcare products and services. The company specializes in the distribution of Western pharmaceuticals, traditional Chinese medicine (TCM), medical equipment, and health supplements. Its operational model integrates physical storefronts with digital platforms to facilitate online-to-offline (O2O) services, including prescription fulfillment and health consultations. Key offerings include chronic disease management, professional pharmaceutical advice, and a diverse inventory of over-the-counter (OTC) medications. The company focuses on community-based health accessibility, utilizing a robust supply chain to ensure product quality and availability across its service regions.

Recent filings

Filing Released Lang Actions
关于使用部分暂时闲置自有资金进行现金管理的进展公告
Regulatory Filings Classification · 1% confidence The document is a corporate announcement (“公告”) by YXT Health (一心堂药业集团股份有限公司) disclosing the progress of using temporarily idle internal funds for cash management products (structured deposits, money market, etc.). It contains the board resolution background, contract details with banks, risk analysis, and tables of past investments over the last 12 months. It is not an earnings release, board change, M&A, or dividend notice, nor is it a full annual or interim report. It is a mandatory regulatory announcement of a non-standard matter (use of idle cash). Therefore it best fits the “Regulatory Filings” fallback category (RNS).
2026-04-23 Chinese
关于控股子公司四川本草堂药业有限公司向银行申请授信额度提供担保的进展公告
Capital/Financing Update Classification · 1% confidence The document is an official announcement (“公告”) by one company that it will provide a guarantee for its subsidiary’s bank credit facilities and details the amount, terms, and progress of the guarantee. This is not a dividend, proxy, ESG, or management change notice, nor is it the full financial report itself. It specifically updates investors on a financing-related corporate action (the provision of guarantees for bank credit), fitting the definition of a Capital/Financing Update. Therefore, the correct classification is CAP.
2026-04-23 Chinese
关于购买房产的进展公告
Regulatory Filings Classification · 1% confidence The document is a corporate announcement detailing the progress of a property purchase by YXT Health (一心堂药业集团股份有限公司). It discloses the acquisition of real estate, property certificates, and associated details as required by the Shenzhen Stock Exchange. It is not a financial report, earnings release, management change, or any other specific category, but rather a regulatory disclosure of a corporate asset transaction. This falls under the fallback category of Regulatory Filings (RNS).
2026-04-16 Chinese
关于使用部分暂时闲置自有资金进行现金管理到期收回的公告
Regulatory Filings Classification · 1% confidence The document is a standalone stock exchange announcement by YXT Health (一心堂) regarding the maturity and recovery of short‐term cash investments made with idle company funds. It details bank counterparties, product names, amounts, maturities, and yields; it is not a management discussion, earnings release, AGM material, share issuance, or rate change notice, nor is it an announcement of publication of a separate report. It falls into the general regulatory announcement category for miscellaneous filings.
2026-04-16 Chinese
第七届董事会2026年第一次独立董事专门会议审核意见
Regulatory Filings Classification · 1% confidence The document is the independent directors’ special meeting review opinion on a board proposal (using own funds for fundraising project replacement). It is not announcing a change in board/management, nor is it an audit report on financials, nor an earnings release. It does not fit into any specific category other than a miscellaneous regulatory announcement. Therefore it is best classified under the fallback category “Regulatory Filings (RNS).”
2026-04-15 Chinese
第七届董事会第一次会议决议公告
Board/Management Information Classification · 1% confidence The document is a resolution announcement of the first meeting of the seventh board of directors (a board decision notice), outlining attendance, reviewed proposals, and voting results. It is not a full annual/interim report, earnings release, dividend notice, nor a proxy solicitation packet. It falls under Board/Management Information (MANG) for disclosures related to board meetings and resolutions.
2026-04-15 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.